Xeris Biopharma Holdings, Inc. XERS Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Xeris Biopharma Holdings, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Xeris Biopharma Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xeris Biopharma Holdings, Inc.'s asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xeris Biopharma Holdings, Inc.'s asset turnover?
- Xeris Biopharma Holdings, Inc. (XERS) reported asset turnover of 0.9× in Q1 2026.
- How has Xeris Biopharma Holdings, Inc.'s asset turnover changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s asset turnover increased by 30.4% year-over-year, from 0.7× to 0.9×.
- What is the long-term trend for Xeris Biopharma Holdings, Inc.'s asset turnover?
- Over 4 years (2021 to 2025), Xeris Biopharma Holdings, Inc.'s asset turnover has grown at a 40.2% compound annual growth rate (CAGR), from 0.2× to 0.8×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.